EP0255243B1 - Dérivés d'azole utiles pour combattre les maladies des plantes - Google Patents

Dérivés d'azole utiles pour combattre les maladies des plantes Download PDF

Info

Publication number
EP0255243B1
EP0255243B1 EP87305856A EP87305856A EP0255243B1 EP 0255243 B1 EP0255243 B1 EP 0255243B1 EP 87305856 A EP87305856 A EP 87305856A EP 87305856 A EP87305856 A EP 87305856A EP 0255243 B1 EP0255243 B1 EP 0255243B1
Authority
EP
European Patent Office
Prior art keywords
compound
formula
defined above
hydrogen
fungicidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP87305856A
Other languages
German (de)
English (en)
Other versions
EP0255243A1 (fr
Inventor
Takashi Maeda
Takahiro Kataoka
Takayuki Hatta
Masaru Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to AT87305856T priority Critical patent/ATE63904T1/de
Publication of EP0255243A1 publication Critical patent/EP0255243A1/fr
Application granted granted Critical
Publication of EP0255243B1 publication Critical patent/EP0255243B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B15/00—Attaching articles to cards, sheets, strings, webs, or other carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Definitions

  • the present invention relates to novel azole derivatives, a process for producing the same and a preparation for controlling plant diseases containing the same.
  • Japanese Patent Publication No. 60-11904 discloses a compound of the formula: wherein m and q are independently integers of 1 or 2; n is an integer of 0 to 3; )( is hydrogen or chlorine; Y is hydrogen, alkyl, methoxy, chlorine or nitro; R 1 is oxygen or sulfur; R 2 is oxygen, sulfur or methylene; R 3 is phenyl or thienyl; and one of R 4 and R 5 is imidazolyl and the other is phenyl, or R 4 and R 5 taken together form alkylidene, and an acid addition salt thereof.
  • Japanese Patent Laid Open Publication No. 60-155163 discloses an imidazole compound of the formula: wherein R is a straight or branched chain alkyl having 6 to 9 carbon atoms, and an acid addition salt thereof.
  • the compound (XI) has excellent antifungal activity and is useful as an industrial fungicide which can effectively prevent the growth of various fungi in industrial materials and products.
  • EP 0162359 discloses imidazole derivatives useful as anti-mycotic agents for humans and animals or agricultural fungicides.
  • novel compounds of the formula wherein R 1 is hydrogen, alkyl having 1 to 12 carbon atoms, or -CH 2 R 4 ; R 2 and R 3 are hydrogen, bromine or methyl; R 4 is alkenyl having 2 to 9 carbon atoms or alkynyl having 2 to 9 carbon atoms; m is an integer of 0 to 2; n is an integer of 0 or 1; p and q are independently integers of 1 to 8; Az is imidazolyl or 1,2,4-triazolyl, Q is -CO-, -0- or -CO-NR 5- ; R 5 is hydrogen or methyl, Y is hydrogen, fluorine, chlorine or phenyl; and Z is hydrogen, fluorine, chlorine or methyl, provided that, when Z is hydrogen, methyl, or chlorine, n is 1.
  • the compounds may be as salts thereof.
  • the present invention also provides a process for producing the compound of the formula (I) and preparations for controlling plant diseases which contain as an active ingredient a compound of the formula (I).
  • examples of the alkyl group R 1 having 1 to 12 carbon atoms include propyl, butyl, octyl, decyl and dodecyl.
  • examples of the alkenyl having 2 to 9 carbon atoms of R 4- include vinyl, propenyl and butenyl, and examples of the alkynyl having 2 to 9 carbon atoms include ethynyl, butynyl and hexynyl.
  • benzyl As there are included benzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2,4-dichlorobenzyl, 3,4-dichlorobenzyl, 2,6-dichlorobenzyl, 4-phenylbenzyl, phenethyl, 4-phenylbutyl, 6-phenylhexyl and the like and, as there are included phenacyl, 2-phenoxyethyl and methylphenylcarbamoylmethyl, for example.
  • the process of Scheme 1 can be carried out by reacting the phenol (II) with the reagent (III) in the presence of a base, or reacting the alkaline metal phenolate (II) with the reagent (III).
  • a base include sodium hydroxide, sodium hydride, potassium amide and sodium ethoxide.
  • the reaction may be carried out in a suitable inert solvent, for example, dimethylformamide, benzene, methanol, chloroform or tetrahydrofuran and at room temperature, for example.
  • the phenol (II) used as the starting material is synthesized by, for example, the following reaction:
  • the process of Scheme 2 is the reaction of acetophenone (IV) with N,N'-thionyldiimidazole to effect addition of imidazole and dehydration simultaneously or sequentially to form the ethenylene (la).
  • the reaction may be carried out in a suitable solvent at room temperature, or with cooling or heating.
  • the solvent there can be used dimethyl sulfoxide, acetonitrile, dimethylformamide, methylene chloride, chloroform orl,2-dichloroethane, for example.
  • the acetophenone (IV) used as the starting material may be obtained by the following reaction: wherein R 1 , A, M and Z are as defined above. This reaction can be carried out according to the reaction of Scheme 1.
  • the process of Scheme 3 can be carried out by reacting the ketone (V) with the alkylidene phosphorane (VI).
  • This reaction can be carried out in a suitable inert solvent, for example, dimethyl sulfoxide, diethyl ether, dioxane, tetrahydrofuran, or benzene, generally at room temperature to 150° C.
  • a suitable inert solvent for example, dimethyl sulfoxide, diethyl ether, dioxane, tetrahydrofuran, or benzene, generally at room temperature to 150° C.
  • the ketone (V) used as the starting material is synthesized according to a known method as shown in the following reaction:
  • the alkylidene phosphorane reagent (VI) can be obtained by treating a phosphonium compound of the formula: wherein A is Cl, Br or I, with a base.
  • a base there can be used carbon bases such as butyl lithium, phenyl lithium, etc.; nitrogen bases such as sodium amide, lithium diethyl amide, DBU, DBN, etc.; oxygen bases such as sodium hydroxide, potassium-t-butoxide, potassium carbonate, etc.; sodium hydride, for example.
  • the process of Scheme 4 can be carried out by reacting the phenol (VII) with the reagent (III), or reacting the alkaline metal phenolate (VII) with the reagent (III).
  • the reaction can be carried out in the same manner as described in Scheme 1.
  • the phenol (VII) used as the starting material may be synthesized by a known method from a compound prepared in the same manner for preparing the ketone (V) as described in Scheme 3, for example, as shown in the following reaction:
  • the process of Scheme 5 can be carried out by reacting the allyl compound (VIII) with the azole (IX) in the presence of a base or reacting the allyl compound (VIII) with the alkaline metal salt of the azole (IX).
  • a base there can be used sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, potassium carbonate or imidazole, for example.
  • the reaction may be carried out in an inert solvent, for example dimethylformamide, dimethyl sulfoxide, benzene, chloroform, or tetrahydrofuran, generally at room temperature to 80 C.
  • the allyl compound (VIII) used as the starting material may be synthesized by a known method from a compound prepared in the same manner as ketone (V) described in Scheme 3, for example, as shown in the following reaction:
  • the compound (I) thus obtained can be converted into a pharmaceutically acceptable acid addition salt.
  • the salt include those formed with organic salts such as acetic acid, citric acid, tartaric acid, malic acid, succinic acid, oxalic acid or methanesulphonic acid, for example, and inorganic salts such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid or phosphoric acid, for example.
  • the fungicidal compounds (I), optionally as a salt thereof, have strong fungicidal activity and are useful for agricultural and industrial fungicides.
  • the fungicidal compounds (I) of the present invention show strong fungicidal activity against plant pathogenic microorganisms such as those for grey mold diseases, sclerotia diseases, powdery mildew and the like.
  • the compounds (I), optionally as salts thereof, invention can be used alone or in combination with one or more solid or liquid carriers, diluents or excipients as an agricultural or garden fungicide in the form of an emulsion, an aqueous solution, wettable powder, dust, a suspension, granules, aerosol, a fumigant or a paste, for example.
  • solid carriers, diluents and excipients include clay, talc, diatomaceous earth, silica, kaolin, bentonite and pumice.
  • liquid carriers examples include water, methanol, ethanol, ethylene glycol, dimethylformamide, dimethyl sulfoxide, acetone, methyl ethyl ketone, cellosolve, dioxane, and diglyme.
  • suitable auxiliaries such as emulsifiers, dispersing agents, spreaders, surfactants, wetting agents and stabilizers, synergists, for example.
  • the compounds (I) of the present invention can be used in combination with other agricultural chemicals such as other fungicides, germicides, insecticides, herbicides, repellents, acaricides, nemato- cides and plant growth regulators, for example.
  • the concentration of the active ingredient in the preparation is not limited to a specific range and varies depending upon the variety of plant to be treated and its growth period. However, in the case of sprinkling the preparation to prevent or treat plant diseases, the concentration of the active ingredient is, for example, 10 to 1,000 ppm, preferably, 50 to 500 ppm.
  • Example 28 In the same manner as in Example 28, the title compound (m.p. 160 - 162) was obtained except that 2-[2-(2,4-dichlorobenzyloxy)-5-fluorophenyl]-3-(imidazol-1-yl)-1-propene was used instead of 2-[2-(2,4-dich- lorobenzyloxy)phenyl]-3-(imidazol-1-yl)-1-propene.
  • Example 34 In the same manner as in Example 34, the title compound (m.p. 139 - 141 ° C) was obtained except that ⁇ - (imidazol-1-yl)-2-(2,4-dichlorobenzyloxy)-5-methylacetophenone was used instead of ⁇ - (1,2,4-triazol-1-yl)-2-(2,4-dichlorobenzyloxy)acetophenone.
  • Example 34 In the same manner as in Example 34, the title compound (m.p. 159 - 161 ° C) was obtained except that ⁇ - (imidazol-1-yl)-2-(2,4-dichlorobenzyloxy)-5-chloroacetophenone was used instead of ⁇ - (1,2,4-tirazol-1-yl)-2-(2,4-dichlorobenzyloxy)acetophenone.
  • the extract was washed with water (50 ml x 2) and dried over anhydrous sodium sulfate. After distilling off the solvent, the residue was subjected to chromatography on a silica gel column and eluted with methylene chloride/methanol to obtain the title compound (0.41 g, 55.9%), m.p. 90 - 92° C (recrystallized from ethyl acetate/n-hexane).
  • Example 72 In the same manner as in Example 72, the title compound (m.p. 113 - 1150 C) was obtained except that ⁇ - (imidazol-1-yl)-2-(2,4-dichlorobenzyloxy)acetophenone was used instead of ⁇ - -(imidazol-1-yl)-2-(2,4-dichlorobenzyloxy)-5-fluoroacetophenone.
  • 1,2,4-Triazole (59 mg, 0.854 mmole) and potassium carbonate (129 mg, 0.933 mmole) were suspended in dimethylformamide (1 ml) and a solution of 2-[2-(2,4-dichlorobenzyloxy)phenyl]-3-bromo-1-propene (290 mg, 0.779 mmole) in dimethylformamide (2 ml) was added dropwise to the suspension. Then, after stirring overnight at room temperature, the reaction mixture was worked up according to the same manner as in Example 25 to obtain the title compound (0.20 g, 71.2%). By comparing I H-NMR and Rf value of TLC of the resulting compound with those of the product of the alternative process described in Example 34, it was confirmed that both chemical structures were identical with each other.
  • o-Hydroxyacetophenone 40.85 g, 300 mmole was dissolved in dimethyl sulfoxide (150 ml) and potassium carbonate (49.0 g, 355 mmole) was added to the mixture. Then, 2,4-dichlorobenzyl chloride (65.9 g, 337 mmole) was added dropwise with stirring. Stirring was continued at room temperature for 24 hours and water (225 ml) was added dropwise over 1 hour. After stirring at room temperature for an additional 1 hour, the precipitated crystals were filtered off, washed with water (200 ml x 3) and recrystallized from methanol to obtain the title compound (82.7 g, 93.4%), m.p. 83 - 85 C.
  • 2-(2,4-Dichlorobenzyloxy)acetophenone (29.52 g, 100 mmole) was dissolved in a mixture of diethyl ether (100 ml) and 1,4-dioxane (100 mmole) and bromine (16 g, 100 mmole) was added dropwise over 1 hour. After stirring at the same temperature for an additional 1 hour, water (200 ml) was added and the mixture was separated into layer. The aqueous layer was extracted with diethyl ether (200 ml). The organic layers were combined, washed with 1% aqueous solution of sodium bicarbonate (180 ml) and dried over anhydrous sodium sulfate.
  • methylmagnesium bromide 14 ml, 3 mole/1 diethyl ether solution; methylmagnesium bromide 42 mmole
  • 2-(2,4-dichloroben- zyloxy)acetophenone 5.0 g, 16.9 mmole
  • molecular sieve 40 ml
  • the extract was washed with water (75 ml x 2) and dried over anhydrous sodium sulfate.
  • the solvent was distilled off under reduced pressure to obtain an oily residue.
  • the residue was dissolved in benzene (40 ml) and p-toluenesulfonic acid monohydrate (0.33 g, 1.73 mmole) was added to the solution.
  • the mixture was refluxed with stirring for 1 hour.
  • the mixture was poured into water (50 ml) and extracted with benzene (50 ml x 2).
  • the extract was washed with water (50 ml) and dried over anhydrous sodium sulfate.
  • n 19.6 1.5831; 'H-NMR(CDCl 3 , 5) : 2.17 (s, 3H, CH 3 ), 5.00 - 5.27 6.77 - 7.70 (m, 7H, aromatic).
  • a solution (12 ml) containing a compound to be tested in a predetermined concentration was sprinkled on the first leaf of a single planting soil culture cucumber plantlet (variety: Tsukuba Shiroibo) in a plastic cup of 9 cm in diameter in a greenhouse, and then air-dried. After 24 hours, spores or a mat of hyphae of Botrytis cinerea were inoculated, and cucumber was kept for 2 to 4 days under conditions of temperature of 20 ⁇ 2 C and humidity of 90 to 100%. Then, the diameter of a disease spot formed was measured and the rate of prevention was calculated from the following formula. The result are shown in Table 1.
  • a mat of hyphae of Botrytis cinerea was inoculated on the first leaf of a single planting soil culture cucumber plantlet (variety: Tsukuba Shiroibo) in a plastic cup of 9 cm in diameter in a greenhouse to slightly cause disease (after about 1 day). Then, a solution (12 ml) containing a compound to be tested in a predetermined concentration was sprinkled and cucumber was kept for 48 hours under conditions of temperature of 20 ⁇ 2 C and humidity of 90 to 100%. The rate of prevention was calculated as described above.
  • a solution (12 ml) containing a compound to be tested in a predetermined concentration was sprinkled on the first leaf of a single planting soil culture cucumber plantlet (variety: Tsukuba Shiroibo) in a plastic cup of 9 cm in diameter in a greenhouse, and air-dried. After 24 hours, a suspension of spores of Sphaerotheca fuliginea was inoculated and cucumber was kept for 14 days under conditions of temperature of 25 ⁇ 2 C and humidity of about 50%. The result was evaluated according to the prevention index which is corresponding to the following sign appearing rate to determine the prevention rate. The results are shown in Table 1.
  • a suspension of spores of Sphaerotheca fuliginea was inoculated on the first leaf of a single planting soil culture cucumber plantlet (variety: Tsukuba Shiroibo) in a plastic cup of 9 cm in diameter in a greenhouse to slightly cause disease (after about 2 days). Then, a solution (12 ml) containing a compound to be tested in a predetermined concentration was sprinkled and cucumber was kept for 12 days under conditions of temperature of 25 ⁇ 2°C and humidity of about 50%. The rate of prevention was determined as described above. The results are shown in Table 1.
  • the compound of the present invention (5 parts), propylene alcohol (20 parts), polyoxyethylene alkylphenyl ether (5 parts) and water (70 parts) are admixed to obtain an aqueous solution.
  • the solution is diluted so that the concentration of the compound of the present invention is 10 to 500 ppm and is sprinkled on leaves and stems.
  • the compound of the present invention (50 parts), sodium alkylbenzene sulfonate (6 parts), sodium lignin sulfonate (4 parts) and clay (40 parts) are admixed and pulverized to obtain a wettable powdery preparation.
  • This preparation is diluted so that the concentration of the compound of the present invention is 10 to 500 ppm and is sprinkled on fruits.
  • the compound of the present invention (5 parts), a mixture of equal amounts of bentonite and talc (90 parts) and sodium alkylbenzene sulfonate (5 parts) are admixed and pulverized. Then, the mixture is granulated to obtain a granular preparation.
  • the compound of the present invention (25 parts), polyoxyethylene alkylphenyl ether (8 parts), sodium alkylbenzene sulfonate (2 parts) and xylene (65 parts) are admixed and emulsified to obtain an emulsion.
  • This emulsion is diluted so that the concentration of the compound of the present invention is 50 to 500 ppm and is sprinkled on leaves and stems.
  • the compound of the present invention (1 part) and talc (99 parts) are admixed to obtain a powdery preparation.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (10)

1. Un composé de formule :
Figure imgb0063
dans laquelle R1 est l'hydrogène, un alkyle ayant de 1 à 12 atomes de carbone,
Figure imgb0064
ou -CH2R4 ; R2 et R3 désignent l'hydrogène, le brome ou le méthyle ; R4 est un alcényle ayant de 2 à 9 atomes de carbone ou un alcynyle ayant de 2 à 9 atomes de carbone ; m est un nombre entier de 0 à 2 ; n est un nombre entier de 0 ou 1 ; p et q sont indépendamment des nombres entiers de 1 à 8 ; Az est un imidazolyle ou 1,2,4-triazolyle, Q est -CO-, -O- ou -CO-NRS- ; R5 est l'hydrogène ou le méthyle ; Y est l'hydrogène, le fluor, le chlore ou le phényle ; et Z est l'hydrogène, le fluor, le chlore ou le méthyle à la condition que, lorsque Z est l'hydrogène, le méthyle ou le chlore, n est 1, le composé pouvant être éventuellement sous la forme d'un sel.
2. Un composé selon la revendication 1, selon lequel l'alkyle est le propyle, le butyle, l'octyle, le décyle ou le dodécyle ; l'alcényle est le vinyle, le propényle ou le butényle ; l'alcynyle est l'éthynyle, le butynyle ou l'hexynyle ;
Figure imgb0065
est le benzyle, le 3-chlorobenzyle, le 4-chlorobenzyle, le 2,4-dichlorobenzyle, le 2,6-dichlorobenzyle, le 4-phénylbenzyle, le phénéthyle, le 4-phénylbutyle, le 6-phénylhexyle ; ou bien
Figure imgb0066
est le phénacyle, le 2-phénoxyéthyle ou le méthylphénylcarbamoylméthyle.
3. 1-[1-[2-(2,6-dichlorobenzyloxy)-5-fluoraphënyl]vinyl]-1H-imidazole.
4. Un procédé de production d'un composé de formule (I) tel que défini dans la revendication 1, qui comprend
A) dans le cas de la production d'un composé de formule (I) dans laquelle n est 0,
(a) la réaction d'un composé de formule :
Figure imgb0067
dans laquelle R2, R3, Az et Z sont comme définis dans la revendication 1 ; et M est l'hydrogène ou un métal alcalin, avec un composé de formule : R1 A (III) dans laquelle R1 est comme défini dans la revendication 1 ; et A est un groupe séparable, ou bien
(b) la réaction d'un composé de formule :
Figure imgb0068
dans laquelle R1 et Z sont comme définis dans la revendication 1, avec un composé de formule : (Az)2SO dans laquelle Az est comme défini dans la revendication 1, ou bien
B) dans le cas de la production d'un composé de formule (I) dans laquelle n est égal à 1,
(c) la réaction d'un composé de formule :
Figure imgb0069
dans laquelle R1, Az et Z sont comme définis dans la revendication 1, avec un composé de formule :
Figure imgb0070
dans laquelle R2, R3 sont comme définis dans la revendication 1, ou bien
(d) la réaction d'un composé de formule :
Figure imgb0071
dans laquelle R2, R3, Az et Z sont comme définis dans la revendication 1 et M est comme défini précédemment, avec un composé de formule :
Figure imgb0072
dans laquelle R1 et A sont comme définis ci-dessus, ou bien
(e) la réaction d'un composé de formule :
Figure imgb0073
dans laquelle R1, R2, R3 et Z sont comme définis dans la revendication 1 et A est comme défini ci-dessus, avec un composé de formule :
Figure imgb0074
dans laquelle Az et M sont comme définis ci-dessus.
5. Un procédé selon la revendication 4(a) qui comprend la réaction d'un composé de formule :
Figure imgb0075
dans laquelle R2, R3, Az, Z et n sont comme définis dans la revendication 1, avec un composé de formule :
Figure imgb0076
 dans laquelle R1 est comme défini dans la revendication 1 et Hal est un halogène, en présence d'une base et dans un solvant.
6. Formulation fongicide qui comprend comme ingrédient actif un composé de formule (I) selon l'une quelconque des revendications 1 à 3 et éventuellement un ou plusieurs supports, diluants ou excipients formulés pour l'utilisation fongicide.
7. Utilisation d'un composé selon l'une quelconque des revendications 1 à 3, ou une formulation selon la revendication 6 comme fongicide.
8. Utilisation d'un composé selon l'une quelconque des revendications 1 à 3, ou d'une formulation selon la revendication 6 comme fongicide pour l'agriculture ou pour l'horticulture.
9. Une méthode de contrôle des champignons dans les plantes, comprenant l'application au champignon ou à son locus, d'un composé selon l'une quelconque des revendications 1 à 3 ou d'une formulation selon la revendication 6.
10. Une méthode selon la revendication 9, selon laquelle le champignon est un champignon pathogène des plantes.
EP87305856A 1986-07-01 1987-07-01 Dérivés d'azole utiles pour combattre les maladies des plantes Expired - Lifetime EP0255243B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT87305856T ATE63904T1 (de) 1986-07-01 1987-07-01 Azolderivate, geeignet zur bekaempfung von pflanzen-krankheiten.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP155462/86 1986-07-01
JP15546286 1986-07-01

Publications (2)

Publication Number Publication Date
EP0255243A1 EP0255243A1 (fr) 1988-02-03
EP0255243B1 true EP0255243B1 (fr) 1991-05-29

Family

ID=15606580

Family Applications (1)

Application Number Title Priority Date Filing Date
EP87305856A Expired - Lifetime EP0255243B1 (fr) 1986-07-01 1987-07-01 Dérivés d'azole utiles pour combattre les maladies des plantes

Country Status (12)

Country Link
US (1) US4780471A (fr)
EP (1) EP0255243B1 (fr)
JP (1) JPH064598B2 (fr)
KR (1) KR940007312B1 (fr)
AR (1) AR243512A1 (fr)
AT (1) ATE63904T1 (fr)
AU (1) AU591995B2 (fr)
BR (1) BR8703347A (fr)
CA (1) CA1330564C (fr)
DE (1) DE3770361D1 (fr)
ES (1) ES2022896B3 (fr)
GR (1) GR3002027T3 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952232A (en) * 1987-04-29 1990-08-28 E. I. Du Pont De Nemours And Company Antifungal carbinols
DE3812483A1 (de) * 1987-06-27 1989-01-05 Bayer Ag (azolyl-vinyl)-phenol-alkenylether
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds
DE3806089A1 (de) * 1988-02-26 1989-09-07 Basf Ag Azolylmethyloxirane und diese enthaltende fungizide
DE3901723A1 (de) * 1989-01-21 1990-07-26 Bayer Ag Azolyl-derivate
DE4013723A1 (de) * 1990-04-28 1991-10-31 Basf Ag 5-(1,2,4-triazol-1-ylmethyl)-isoxazoline
US7018641B1 (en) * 2000-08-09 2006-03-28 University Of Florida Materials and methods for the control of plant pathogens
JP2007513082A (ja) * 2003-11-10 2007-05-24 シエーリング アクチエンゲゼルシャフト Ｃｃｒ−５アンタゴニストとして有用なベンジルエーテルアミン化合物
CN102408335A (zh) * 2010-09-21 2012-04-11 中国科学院福建物质结构研究所 一种对氟苯基醋酸酯的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
JPS6036427B2 (ja) * 1980-12-05 1985-08-20 塩野義製薬株式会社 １−ベンジルイミダゾ−ル誘導体
DE3327036A1 (de) * 1983-07-27 1985-02-07 Bayer Ag, 5090 Leverkusen 3-(1,2,4-triazol-1-yl)-l-propene
DE3340989A1 (de) * 1983-11-10 1985-05-23 Schering AG, 1000 Berlin und 4709 Bergkamen E-triazolyl-pentenole, verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide und wuchsregulatorische mittel
JPS60155163A (ja) * 1984-01-09 1985-08-15 Mitsui Toatsu Chem Inc イミダゾ−ル誘導体
US4629795A (en) * 1984-05-25 1986-12-16 Shionogi & Co., Ltd. Process for preparing imidazole derivatives
JPS61183285A (ja) * 1985-02-12 1986-08-15 Yoshiki Hamada ビニ−ルイミダゾ−ル誘導体およびその塩
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds

Also Published As

Publication number Publication date
AU591995B2 (en) 1989-12-21
AU7499987A (en) 1988-01-07
KR890002036A (ko) 1989-04-07
ES2022896B3 (es) 1991-12-16
EP0255243A1 (fr) 1988-02-03
JPS63146865A (ja) 1988-06-18
US4780471A (en) 1988-10-25
JPH064598B2 (ja) 1994-01-19
CA1330564C (fr) 1994-07-05
ATE63904T1 (de) 1991-06-15
KR940007312B1 (ko) 1994-08-12
GR3002027T3 (en) 1992-12-30
DE3770361D1 (de) 1991-07-04
BR8703347A (pt) 1988-03-15
AR243512A1 (es) 1993-08-31

Similar Documents

Publication Publication Date Title
US4548945A (en) Fungicidally active substituted 1-hydroxyethyl-triazolyl derivatives
JPS5962576A (ja) トリアゾリル−アルカノ−ルおよびこれらの塩の製造方法
JPH0649043A (ja) アゾリルメチル−フルオロシクロプロピル誘導体
US4871389A (en) Heterocyclic compounds
EP0255243B1 (fr) Dérivés d'azole utiles pour combattre les maladies des plantes
JPS623147B2 (fr)
JPS6337764B2 (fr)
US4495191A (en) Fungicidal 3-1,2,4-triazol-1-yl-1,2-diaryl-1-halogeno-prop-1-ene derivatives, compositions, and method of use
HU192005B (en) Fungicide composition and process for preparing azolyl-3-pyrazolyl-2-propanol derivatives
US4427673A (en) Azolylalkyl ketone and alcohol fungicides
JPS6026111B2 (ja) 新規な１−アゾリル−４−ヒドロキシ−ブタン誘導体，その製造方法およびそれを活性成分として含有する殺菌剤組成物
US4935436A (en) Substituted triazoles and their use as fungicides
EP0272895B1 (fr) Dérivés de l'azole, procédé pour leur préparation et fongicides pour l'agriculture/horticulture contenant ces dérivés comme ingrédient actif
JPS6146474B2 (fr)
US4818762A (en) Fungicidal novel hydroxyalkynyl-azolyl derivatives
US5021442A (en) Fungicide azolyl-derivatives
HU188580B (en) Fungicides containing derivatives of 2,2-dimethil-phenoxi-4-azolil-oktan-3-ol and process for production of the reagents
US4213990A (en) 1,1-Diphenylethene derivatives as microbicides
CA1325637C (fr) Derives azolyles fongicides
US4360528A (en) Combating fungi with 1-azolyl-1-propen-3-ols
US4870092A (en) 1,3-Diazolyl-2-propanols as fungicidal agents
JPH0472831B2 (fr)
US4927833A (en) Substituted azoles and their use as fungicides
US4547515A (en) Azolyl-phenoxy-tetrahydrofuran-2-ylidene-methane fungicidal agents
JPH064599B2 (ja) ヒドロキシエチル‐アゾール誘導体

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19880307

17Q First examination report despatched

Effective date: 19890612

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

REF Corresponds to:

Ref document number: 63904

Country of ref document: AT

Date of ref document: 19910615

Kind code of ref document: T

ET Fr: translation filed
REF Corresponds to:

Ref document number: 3770361

Country of ref document: DE

Date of ref document: 19910704

ITF It: translation for a ep patent filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3002027

EPTA Lu: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19940929

Year of fee payment: 8

EAL Se: european patent in force in sweden

Ref document number: 87305856.4

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19950531

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19950601

Year of fee payment: 9

Ref country code: GR

Payment date: 19950601

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19950602

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19950614

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 19950630

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19950706

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19950728

Year of fee payment: 9

Ref country code: AT

Payment date: 19950728

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19950731

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19960402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19960701

Ref country code: GB

Effective date: 19960701

Ref country code: AT

Effective date: 19960701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19960702

Ref country code: ES

Free format text: LAPSE BECAUSE OF THE APPLICANT RENOUNCES

Effective date: 19960702

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19960731

Ref country code: CH

Effective date: 19960731

Ref country code: BE

Effective date: 19960731

BERE Be: lapsed

Owner name: SHIONOGI SEIYAKU K.K.

Effective date: 19960731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 19970131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19970201

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19960701

REG Reference to a national code

Ref country code: GR

Ref legal event code: MM2A

Free format text: 3002027

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19970328

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 19970201

EUG Se: european patent has lapsed

Ref document number: 87305856.4

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20001102

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050701